Hébert-Croteau Nicole, Brisson Jacques, Lemaire Jacques, Latreille Jean, Pineault Raynald
Direction des Systèmes de Soins et Services, Institut National de Santé Publique du Québec, Montréal, Québec, Canada.
Cancer. 2005 Oct 1;104(7):1343-8. doi: 10.1002/cncr.21336.
To understand the relation between hospital of initial treatment and the survival of women with breast cancer, the authors investigated the characteristics of the treatment center that were related most to outcome.
The authors selected women from 5 regions of Quebec, Canada, who were diagnosed with lymph node-negative breast cancer between 1988 and 1994. Data were collected by chart review, queries to physicians, and linkage with administrative data bases. Overall survival to the end of 1999 was analyzed using the Kaplan-Meier method and Cox proportional hazards models.
The study population included 1727 women with a median follow-up of 6.8 years. The 7-year survival rate was 82% (95% confidence interval [95%CI], 80-84%). Compared with women who were treated in centers with > or = 100 new cases per year, the hazard ratio (HR) of death from any cause was 1.80 (95%CI, 1.23-2.63), 1.44 (95%CI, 1.03-2.03), and 1.30 (95%CI, 0.96-1.76) among women who were treated in hospitals with < 25 new cases, 25-49 new cases, and 50-99 new cases per year after adjusting for case mix and characteristics of the attending physician. However, the significance of caseload disappeared after adjusting for the type of hospital. By contrast, women who were treated in centers with either on-site radiotherapy, research activity, or teaching status had significantly better outcomes, even after adjusting for caseload (HR, 0.68; 95%CI, 0.50-0.92). These associations were independent of primary treatment received, which was a strong determinant of outcome.
Primary treatment of early-stage breast cancer in larger hospitals was associated with improved survival. This relation was mediated by factors related to proficiency of care, which tended to cluster within institutions.
为了解初始治疗医院与乳腺癌女性患者生存率之间的关系,作者调查了与预后最相关的治疗中心特征。
作者从加拿大魁北克省5个地区选取了1988年至1994年间被诊断为淋巴结阴性乳腺癌的女性。通过病历审查、向医生询问以及与行政数据库关联来收集数据。使用Kaplan-Meier方法和Cox比例风险模型分析至1999年底的总生存率。
研究人群包括1727名女性,中位随访时间为6.8年。7年生存率为82%(95%置信区间[95%CI],80 - 84%)。与每年有≥100例新病例的中心接受治疗的女性相比,在每年新病例数<25例、25 - 49例和50 - 99例的医院接受治疗的女性,在调整病例组合和主治医生特征后,任何原因导致死亡的风险比(HR)分别为1.80(95%CI,1.23 - 2.63)、1.44(95%CI,1.03 - 2.03)和1.30(95%CI,0.96 - 1.76)。然而,在调整医院类型后,病例数量的显著性消失。相比之下,在具有现场放疗、研究活动或教学地位的中心接受治疗的女性,即使在调整病例数量后,预后也显著更好(HR,0.68;95%CI,0.50 - 0.92)。这些关联独立于接受的初始治疗,而初始治疗是预后的一个重要决定因素。
大型医院对早期乳腺癌的初始治疗与生存率提高相关。这种关系由与医疗水平相关的因素介导,这些因素往往在机构内聚集。